Clinical Trials Logo
  1. Home
  2. HPV-Related Cervical Carcinoma
  3. NCT03888599
  4. Details
NCT03888599 Clinical Trial

Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination

HPV-Related Cervical Carcinoma Clinical Trial

Official title:
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination Among Undergraduate Health Students From Switzerland

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03888599
Other study ID # Req-2019-00118
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2019
Est. completion date August 1, 2019

Study information
Verified date September 2019
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A better understanding of the target audiences about HPV infection and HPV vaccination would surely allow for a better spread of this vaccination in Switzerland. In order to know if the target audiences are properly informed, we have decided to carry out a study evaluating their level of knowledge on a particular audience that are the men and women undergraduate nurse.

Recruitment information / eligibility
Status Completed
Enrollment 600
Est. completion date August 1, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 36 Years
Eligibility Inclusion Criteria:

- Eligible women and men aged between 18-36 years

- Understands study procedures and accepts voluntarily to participle of the study

Exclusion Criteria:

.Don't understand french language

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• knowledge questioannaire
, all enrolled undergraduate student received directly on your email the online questionnaire based on the "Fluid Survey tool", which was an on line survey tool (https://fluidsurveys.com/)

Locations
Country Name City State
Switzerland Jeannot Geneva

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Questionnaire about basic knowledge HPV infection Percentage of right answer of the questionnaire 3 months
See also
  Status Clinical Trial Phase
Completed NCT04083196 - A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years Phase 1
Recruiting NCT05829629 - Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women Phase 1
Recruiting NCT06052033 - Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection N/A
Active, not recruiting NCT03260023 - Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers Phase 1/Phase 2
Recruiting NCT04857528 - Detecting HPV DNA in Anal and Cervical Cancers
Recruiting NCT03749707 - HPV in Sentinel Lymph Nodes N/A
Recruiting NCT05314907 - Acceptability of Self-sampling for Cervical Cancer Screening N/A
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Recruiting NCT05973487 - A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors Phase 1
Terminated NCT05061940 - This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Recruiting NCT05783167 - Self-collected Vaginal and Urine Samples in HIV-positive Women
Recruiting NCT05996783 - Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial N/A
Active, not recruiting NCT06339684 - HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis
Recruiting NCT05686226 - E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers Phase 2
Not yet recruiting NCT06319963 - A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer Phase 1/Phase 2
Completed NCT05767138 - STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012
Completed NCT04970394 - An Observational Study of GP Verbal Reminders Upon Cervical Screening
Completed NCT03337269 - Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake N/A
Completed NCT04436133 - Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) Phase 2
Completed NCT04480866 - CASUS: Improved and Quality Assured Collection of First-void Urine N/A